A lady was diagnosed in the beginning of August, 2015 with invasive ductal carcinoma, the main tumor in the left breast about 6 cm or about 2.5 inches, other seven lesions in the sternum (or breastbone) and the left lung.  Initially, the breast cancer was staged at 2 by a hospital, but a few weeks later staged at 4 by another cancer clinic.

The diagnosis was confirmed after a series of diagnostic studies including CT scan, PET, bone scan, MRI, brain scan, several mammograms and core biopsy.  The breast cancer was estrogen receptor positive (ER+)/ progesterone receptor positive (PR+)/ HER2 negative.

The patient did not use any typical conventional treatments like surgery, chemotherapy and radiotherapy.  Instead, she used an alternative protocol, and after 10 months of the treatments, her breast cancer disappeared as confirmed by doctors.

The complete protocol she used to treat her breast cancer included a number of anticancer therapies and diagnostic tests ranging from diet, nutrition, functional foods/supplements, use of clinics and specific diagnostics.   The protocol allows use of PET or MRI scans or some hormone blocking drugs, provided by conventional doctors and clinics.  Alternative, Integrative or holistic clinics also need to be used as part of this protocol. 

The cost of the breast cancer treatment she used was about $2,000.00 per month exclusive of the expenses for required food.  The remission was achieved in 10 months.  When conventional treatments are employed, the average cost for stage 4 invasive ductal carcinoma is about $182,655 in 24 months, according to a study released in 2016 in American Health and Drug benefits.

For a moderate fee, the patient is willing to tell any other patient with similar disease what she did to defeat breast cancer in detail.   She can communicate with phone, Skype, FaceTime, or email or in person if she can be compensated for expenses for the transportation and lodging.

Interested readers may contact us at foodconsumer.org@gmail.com and we will get you in contact with this lady.  

Disclaimer:  The breast cancer survivor does not sell or promote any products.  She does not claim that the protocol she used would help others as well.  The treatment like all other alternative cancer treatments has not been evaluated nor approved by the Food and Drug Administration.  Any service rendered by the cancer survivor will earn us a referral fee.

What is stage 4 invasive ductal carcinoma?

Stage 4 invasive ductal carcinoma is a life-threatening disease and the five-year survival is estimated at 22% if the disease is treated with conventional therapies.

Stage 4 means that the cancer has spread out of the breast to the bone, lung, liver or brain.  Like in the case reported here, the lady's cancer has spread to the lung.   Invasive means that the cancer has spread to the lymph nodes and possible elsewhere.  Ductal means that the cancer began in the milk ducts which are the pipes that allow milk to flow through from the milk-producing lobules to the nipple.  Carcinoma means that the cancer begins in the skin or tissues that cover internal organs such as breast tissue.

Up to 80% of breast cancer or 180,000 breast cancer cases each year in the United States are diagnosed as invasive breast cancer.  This disease like many other types of cancer is more often diagnosed in women aged 50 or older.

Symptoms of invasive ductal carcinoma include swelling of all or part of the breast, irritation or dimpling, pain, the nipple turning inward, redness, abnormal complexion of the breast, abnormal nipple discharge, a lump in the underarm area.  Anything abnormal may indicate some disease of the breast.

Stage 4 invasive ductal carcinoma conventionally requires systemic treatments such as chemotherapy, hormonal therapy and targeted therapies.  Surgery may not be useful in the case as the cancer has already spread, meaning that surgery could not "completely" remove all cancerous cells.  Radiotherapy may not be applicable in this case.

The commonly used chemotherapy drugs include Adriamycin (doxorubicin),Ellence (epirubicin), Cytoxan (cyclophosphamide), Taxotere (docetaxel), Taxol (paclitaxel), Xeloda (chemical name: capecitabine), Ixempra (ixabepilone), methotrexate, fluorouracil (also called 5-fluorouracil or 5-FU).

Also used are hormone therapies and HER2-targeted therapies.

The common adverse effects associated with cancer treatments include fatigue, alopecia, sexual dysfunction, thrombocytopenia or low platelet count, damages to the brain, the liver, the kidney and the heart. 

The overall five year survival rate for invasive ductal carcinoma may be around 80%, but some studies suggest 60%. The survival rate can be much lower in cases like the one reported here.  According to American Cancer Society, breast cancer that has spread to other parts of the body is more difficult to treat and tend to have a poor prognosis.  A five year survival for metastatic or stage 4 breast cancer is about 22%.